Close Menu

You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.

Home » coronavirus

coronavirus

Breaking news on coronavirus testing, with real-time reporting on assays to detect the SARS-CoV2 coronavirus, which causes COVID-19. 

Check out our Coronavirus Test Tracker for the latest information on the regulatory status of these tests in the US, European, and Asian markets.

Sep 25, 2020

Mutations in Type I Interferon Immunity Genes Underlie Severe COVID-19

A portion of patients with life-threatening COVID-19 pneumonia had inborn errors of TLR3- and IRF7-dependent type I IFN immunity.

Sep 25, 2020

Cepheid Multiplex SARS-CoV-2, Flu, RSV Test Nabs FDA Emergency Use Authorization

The test runs on multiple GeneXpert systems and tests nasopharyngeal and nasal swabs or nasal wash/aspirate specimens.

Sep 25, 2020

ASU Team Wins $6M in Government Funding to Develop Rapid Saliva Testing System for Coronavirus

The test will be designed to run on a portable device that can ultimately be rolled out to point-of-need settings such as doctors' offices and workplaces.

Sep 25, 2020

This Time, Novavax

Novavax has begun a phase III trial of its SARS-CoV-2 vaccine, according to the New York Times.

Sep 25, 2020

New York's Own Review

The governor of New York says the state will conduct its own review of any SARS-CoV-2 vaccine, NPR reports.

Sep 25, 2020

Abacus Diagnostica Readying Multiplex RT-PCR Test for SARS-CoV-2, Flu, RSV

Premium

The assay should have a CE-IVD mark by November and will serve the Finnish molecular diagnostics firm's growing European client base.

Sep 25, 2020

NIH Awardee MatMaCorp Developing SARS-CoV-2 Molecular Test for Rural Hospitals

Premium

The firm said that the shortage of testing in rural America highlights a need for its rapid molecular system, which is small enough to fit in a backpack.

Sep 24, 2020

BARDA Awards $5.4M to Luminex for Expanded Respiratory Panel With Coronavirus Target

The extended molecular panel combines SARS-CoV-2 with other common respiratory pathogen targets. It includes 19 viral and two bacterial targets.

Sep 24, 2020

BGI Genomics Gets CE Mark for Multiplexed SARS-CoV-2, Influenza Tests

Both RT-PCR tests are for the simultaneous qualitative detection and differentiation of SARS-CoV-2, influenza A, and influenza B from throat swab samples.

Sep 24, 2020

And Maybe Not

President Donald Trump might not approve the stricter standards the US Food and Drug Administration is developing for authorizing a SARS-CoV-2 vaccine, according to Politico.

Pages

The Scan

This Time, Novavax

Novavax has begun a phase III trial of its SARS-CoV-2 vaccine, according to the New York Times.

Shortened Visas for Some Students

Vox reports that the Trump Administration may limit student visas for individuals from some countries to two years.

New York's Own Review

The governor of New York says the state will conduct its own review of any SARS-CoV-2 vaccine, NPR reports.

Science Papers Examine Y Chromosomes of Archaic Humans, Schistosomiasis Therapeutic Targets

This week in Science: Neanderthal Y chromosomes replaced by Homo sapiens Y chromosomes, and more.

What's Popular?

In Infectious Disease

  1. Cepheid Multiplex SARS-CoV-2, Flu, RSV Test Nabs FDA Emergency Use Authorization

  2. Mutations in Type I Interferon Immunity Genes Underlie Severe COVID-19

  3. Clear Labs Nanopore Sequencing Coronavirus Test Gets FDA Emergency Use Authorization

  4. ASU Team Wins $6M in Government Funding to Develop Rapid Saliva Testing System for Coronavirus

  5. BGI Genomics Gets CE Mark for Multiplexed SARS-CoV-2, Influenza Tests

Privacy Policy.  Terms & Conditions.  .  Copyright © 2020 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.